SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-017666
Filing Date
2023-11-06
Accepted
2023-11-06 08:20:51
Documents
14
Period of Report
2023-11-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrbo-20231101x8k.htm   iXBRL 8-K 58075
2 EX-99.1 nrbo-20231101xex99d1.htm EX-99.1 12965
3 GRAPHIC nrbo-20231101xex99d1001.jpg GRAPHIC 7041
  Complete submission text file 0001558370-23-017666.txt   209647

Data Files

Seq Description Document Type Size
4 EX-101.SCH nrbo-20231101.xsd EX-101.SCH 3150
5 EX-101.LAB nrbo-20231101_lab.xml EX-101.LAB 15930
6 EX-101.PRE nrbo-20231101_pre.xml EX-101.PRE 10073
8 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20231101x8k_htm.xml XML 4874
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 231378197
SIC: 2834 Pharmaceutical Preparations